Jefferies Initiates Ultragenyx Pharmaceutical At Buy By: Benzinga via Benzinga September 23, 2014 at 07:33 AM EDT Analysts at Jefferies initiated coverage on shares of Ultragenyx (NASDAQ: RARE) with a Buy rating. The target price for Ultragenyx is ... Read More >> Related Stocks: Ultragenyx Pharmaceu